NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE59701 Query DataSets for GSE59701
Status Public on Mar 13, 2015
Title A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets (mRNA)
Organism Homo sapiens
Experiment type Expression profiling by array
Summary MYB activation is proposed to underlie development of adenoid cystic cancer (ACC), an aggressive salivary gland tumor with no effective systemic treatments. To discover druggable targets for ACC, we performed global mRNA/miRNA analyses of 12 ACC with matched normal tissues, and compared these data with 14 mucoepidermoid carcinomas (MEC) and 11 salivary adenocarcinomas (ADC). We detected a unique ACC gene signature of 1160 mRNAs and 22 miRNAs. MYB was the top-scoring gene (18-fold induction), however we observed the same signature in ACC without detectable MYB gene rearrangements. We also found 4 ACC tumors (1 among our 12 cases and 3 from public databases) with negligible MYB expression that retained the same ACC mRNA signature including over-expression of extracellular matrix (ECM) genes. Integration of this signature with somatic mutational analyses suggests that NOTCH1 and RUNX1 participate with MYB to activate ECM elements including the VCAN/HAPLN1 complex. We observed that forced MYB-NFIB expression in human salivary gland cells alters cell morphology and cell adhesion in vitro and depletion of VCAN blocked tumor cell growth of a short-term ACC tumor culture. In summary, we identified a unique ACC signature with parallel MYB-dependent and independent biomarkers and identified VCAN/HAPLN1 complexes as a potential target.
 
Overall design A total 12 human salivary gland adenoid cystic cancer and 12 mathced normal adjacent tissues. The 12 tumor samples contains 8 MYB-NFIB fusion positive tumor samples and 4 MYB-NFIB fusion negative samples. One of the 4 fusion negative tumors did not have high MYB expression. This is a mRNA whole exome expression assay.
 
Contributor(s) Gao R, Cao C, Zhang M, Maria-Cecilia L, Yan Y, Chen Z, Mitani Y, Zhang L, Zajac-Kaye M, Liu B, Wu L, Renne R, Baker HV, El-Naggar A, Kaye FJ
Citation(s) 25587024
Submission date Jul 23, 2014
Last update date Jul 26, 2018
Contact name Nicholas Navin
Organization name UT MD Anderson
Street address 6767Bertner AVE
City Houston
State/province tx
ZIP/Postal code 77030
Country USA
 
Platforms (1)
GPL6244 [HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]
Samples (24)
GSM1443185 Fusion positive tumor; biological rep1
GSM1443186 Fusion positive tumor; biological rep2
GSM1443187 Match normal of fusion positive tumor; biological rep1
This SubSeries is part of SuperSeries:
GSE59702 A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets
Relations
BioProject PRJNA255982

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE59701_RAW.tar 105.5 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap